CareCloud (NASDAQ:CCLD) Issues Earnings Results, Hits Expectations

CareCloud (NASDAQ:CCLD) issued its earnings results on Thursday. The company reported $0.11 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.11, FiscalAI reports. The company had revenue of $34.42 million for the quarter, compared to analysts’ expectations of $32.10 million. CareCloud had a net margin of 8.96% and a return on equity of 24.96%. CareCloud updated its FY 2026 guidance to 0.200-0.23 EPS.

Here are the key takeaways from CareCloud’s conference call:

• For 2025 CareCloud delivered a financial turnaround — $120.5M revenue (≈9% YoY), GAAP net income $10.8M (first full-year positive EPS since IPO, $0.10), $20.5M free cash flow, and 2026 guidance of $128–130M revenue and EPS $0.20–$0.23.
• Strategic M&A expanded the addressable market — the Medsphere and MAP App deals added inpatient/hospital products (Wellsoft, HealthLine) and >100 hospitals, were funded from free cash flow at <1x revenue and caused no common-share dilution, creating a cross-sell runway for RCM and AI.
• AI is now core to the go‑forward plan — the AI Center of Excellence and product launches (notably stratusAI Desk Agent, Voice Audit, cirrusAI Notes) are in production with early customer traction (one client reports ~80% of inbound scheduling calls handled) and roadmap items (coding, prior auth, “zero‑touch” claims) targeted for 2026 monetization.
• Liquidity and execution risks remain — year‑end cash was modest (~$3.6M) despite strong free cash flow, the company resumed and will double Series B preferred dividends to clear arrearages, guidance excludes any unannounced material M&A, and broader market skepticism of AI/SaaS valuations could weigh on the stock until consistent AI revenue/metrics are proven.

CareCloud Stock Performance

CCLD stock opened at $3.14 on Friday. The firm has a market cap of $133.14 million, a price-to-earnings ratio of 39.25 and a beta of 2.09. The firm has a 50-day simple moving average of $2.68 and a two-hundred day simple moving average of $3.06. CareCloud has a one year low of $1.14 and a one year high of $4.01. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.24 and a current ratio of 1.26.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CCLD. ThinkEquity assumed coverage on shares of CareCloud in a research report on Monday, November 24th. They issued a “buy” rating for the company. Weiss Ratings reissued a “hold (c-)” rating on shares of CareCloud in a report on Monday, December 29th. Finally, Wall Street Zen upgraded CareCloud from a “buy” rating to a “strong-buy” rating in a report on Saturday, February 14th. One analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $3.25.

More CareCloud News

Here are the key news stories impacting CareCloud this week:

• Positive Sentiment: CareCloud reported record net income and its first full-year positive EPS since IPO, said it exceeded revenue guidance, and introduced new generative AI products — a fundamental update that supports growth and margin narrative. Read More.
• Positive Sentiment: Q4 revenue beat consensus ($34.42M vs. $32.10M) and EPS matched estimates at $0.11, signaling revenue momentum even as year-over-year EPS fell; management provided supplemental materials (press release/slide deck) for investors. Read More.
• Positive Sentiment: Zacks Research raised its FY2026 EPS forecast (from $0.43 to $0.45) and published updated quarterly/FY2027 estimates, reflecting analyst model adjustments after the results. Read More.
• Neutral Sentiment: Zacks published detailed quarterly estimates (Q2–Q4 2026 and FY2027), which give investors a roadmap for expected cadence but do not materially change consensus yet. Read More.
• Neutral Sentiment: Reported short-interest data in recent feeds shows anomalous “0 shares / NaN” entries; the published short-interest figures appear unreliable and should be treated cautiously. (Data items from March filings showed inconsistent values.)
• Negative Sentiment: CareCloud set FY2026 EPS guidance at $0.20–$0.23, below the consensus (~$0.24), and gave revenue guidance of $128–$132M (vs. consensus ~$130.6M) — the lower EPS range is a headwind that likely tempered some investor enthusiasm. Read More.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. HRT Financial LP purchased a new stake in CareCloud during the fourth quarter valued at approximately $43,000. Centiva Capital LP acquired a new stake in CareCloud in the third quarter valued at approximately $47,000. American Century Companies Inc. purchased a new position in CareCloud in the second quarter worth $78,000. Man Group plc purchased a new position in CareCloud in the fourth quarter worth $84,000. Finally, Qube Research & Technologies Ltd acquired a new position in shares of CareCloud during the third quarter worth $87,000. Hedge funds and other institutional investors own 10.16% of the company’s stock.

About CareCloud

CareCloud, Inc is a healthcare technology company that provides cloud-based practice management, electronic health record (EHR) and revenue cycle management (RCM) solutions to medical practices and health systems. Its flagship offering, the CareCloud Central platform, combines clinical, financial and administrative workflows into a single, unified system. The platform includes modules for scheduling, billing, coding, patient engagement and telehealth, enabling practices to streamline front- and back-office operations and improve overall practice performance.

Founded in 2009 and headquartered in Miami Beach, Florida, CareCloud serves small to mid-size physician groups and specialty clinics across the United States.